Jefferies cuts Axsome Therapeutics target price to $305 from $380
AXSM•Jefferies cut its target price for Axsome Therapeutics to $305 from $380.
Related News
Jefferies raises Vulcan Materials target price to $335 from $320
VMC•
KBW cuts KKR Real Estate Finance Trust target price to $5.5 from $6.5
KREF•
argenx participates in Guggenheim and Jefferies healthcare investor conferences
ARGX•
Sirius XM Holdings target price cut to $32 from $34
SIRI•
Lonza agrees to buy five US CDMO sites from Merck
MRK•